{"url_path":"/sec/wgrx/8-k/2026-07-21/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-034086-index.html","accession_number":"0001493152-26-034086","cik":"0002030763","ticker":"WGRX","issuer_name":"Wellgistics Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-034086-index.html","primary_entity_key":"0002030763","primary_entity_name":"Wellgistics Health, Inc."},"word_count":190,"has_tables":true,"body_markdown":"** **\n\n**Item\n5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**\n\n \n\nOn\nJuly 20, 2026, Wellgistics Health, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate\nof Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware to change the name of the\nCompany to “DataMeds AI, Inc.” (the “Name Change”), effective July 22, 2026.\n\n \n\nPursuant\nto Section 242 of the General Corporation Law of the State of Delaware, no stockholder approval was required for the Charter Amendment\nbecause it only related to a name change. A copy of the Charter Amendment is attached hereto as Exhibit 3.1 and is incorporated herein\nby reference.\n\n \n\nIn\nconnection with the Name Change, the Company’s trading symbol for its common stock will begin trading on the Nasdaq Capital Market\non July 22, 2026 as “MEDS” (the “Symbol Change”).\n\n \n\nNeither\nthe Name Change*,* nor the Symbol Change, affects the rights of the Company’s stockholders, and stockholders do not need to\ntake any action in connection with the Name Change or the Symbol Change. The CUSIP number for the Company’s common stock remains\n949503205."}